Sanofi FY 2012 - Interview with CEO Chris Viehbacher
Sanofi FY 2012 - Interview with CEO Chris Viehbacher
PARIS--(BUSINESS WIRE)-- Sanofi, a global and diversified healthcare leader, reports 2012 results. CEO Chris Viehbacher comments on 2012 results and outlook for 2013.
Click to watch the video:http://bit.ly/XkZjhU
Topics covered in the interview include:
- 2012 Results
- Genzyme
- Emerging Markets
- Diabetes franchise
- R&D Pipeline
- Animal Health
- Capital Allocation
- Cost savings
- 2013 Guidance
About Sanofi
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYS: SNY) .
Company website: www.sanofi.com
Sanofi
Investor Relations:
Sébastien Martel, +33 1 53 77 45 45
IR@sanofi.com
or
Media Relations:
+33 1 53 77 45 02
MR@sanofi.com
KEYWORDS: Europe France
INDUSTRY KEYWORDS:
The article Sanofi FY 2012 - Interview with CEO Chris Viehbacher originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
